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ABSTRACT 
The identification of genes based on mutations that alter responsiveness to the 
paralyzing effects of the cholinergic agonist levamisole and the acetylcholinesterase 
inhibitor aldicarb has greatly enhanced our understanding of the mechanisms underlying 
neurotransmitter release and cholinergic signaling in C. elegans.  However, mutations that 
only subtly affect drug sensitivity may still produce significant effects on synaptic function 
and be difficult to isolate in these kinds of screens.  Alternative strategies for probing the 
genetic pathways that regulate neurotransmission may be valuable in identifying these 
classes of genes.  Recent studies of cholinergic signaling in mammals have explored 
potential roles for nicotinic receptors in the mammalian brain by utilizing nAChR knockin 
mice that are hypersensitive to nicotine.  We have generated strains expressing levamisole 
receptor subunits carrying a similar gain-of-function mutation.  These strains are 
hypersensitive to levamisole and aldicarb, are hypercontracted, display exaggerated body 
bends, have kinked noses, and show reduced movement compared to wild type worms.  We 
have used these animals to explore the downstream effects of hyper-activation and have 
found a dramatic effect in the localization of the nAChR acr-16.  To identify new genes that 
may be involved in levamisole receptor signaling we have conducted a forward genetic 
screen for suppressors of the movement phenotype.  We have isolated 15 suppressors, 
many of which retain levamisole sensitivity and thus would not have been isolated from 
traditional levamisole screens.  We believe that this strategy will help us to find novel 
factors that play important roles in cholinergic function. 
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INTRODUCTION 
To understand nervous system function it is essential to know how neurons 
communicate.  Most neuronal communication occurs at specialized points of cell-cell 
contact called synapses.  A chemical messenger, or neurotransmitter, is released at 
synapses from the presynaptic cell and activates receptors located on the postsynaptic cell.  
This process is a universally conserved feature of nervous systems, and deficits in synaptic 
transmission underlie many neurological disorders.  By elucidating mechanisms for the 
regulation of neurotransmission and, in particular, postsynaptic receptors, we hope to 
understand neural function better.  With a better understanding of these mechanisms, we 
hope be able to identify factors important in neuronal plasticity, an essential part of 
learning and memory, and to find potential targets for therapies against diseases that affect 
these synapses. 
THE C. ELEGANS NEUROMUSCULAR JUNCTION 
For our work, we have chosen to study the neuromuscular junction (NMJ) of the 
nematode Caenorhabditis elegans.  C. elegans offers an incredibly useful system for studying 
the basic properties of the nervous system.  On the molecular level, many aspects of the C. 
elegans nervous system are conserved in the mammalian nervous system.  Mutations in 
genes that are important for nervous system function are often lethal in mammals and are 
thus difficult to study.  In contrast, homologous mutations in C. elegans are well tolerated.  
C. elegans are also hermaphroditic, meaning that they do not need to mate in order to 
reproduce.  In the lab, we can culture these animals directly on their bacterial food source, 
allowing survival despite severe movement defects.  Taken together, these traits allow us to 
study deficient nervous systems in intact animals.  C. elegans is also amenable to transgenic 
approaches, allowing us to express wild type and mutated genes of interest under cell-
specific promoters.  The animals are transparent, allowing us to use photomicroscopy to 
study expression patterns and subcellular localization of proteins in live, intact animals 
using florescent reporter molecules such as green florescent protein (GFP).   
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FIGURE 1.  MODEL OF THE C. ELEGANS NMJ.  Previously characterized genes in C. elegans are 
labeled.  Levamisole is an agonist of the levamisole receptor (LevR).  Aldicarb inhibits 
acetylcholinesterase (AChE) causing acetylcholine (ACh) to build up in the synapse .  When 
the synapse is exposed to these drugs, many channels are opened and the postsynaptic 
cell becomes hyperactivated, resulting in muscle contraction and paralysis.  Adapted from 
(Rand, 2007). 
The basic properties of the C. elegans NMJ have been well characterized.  This allows 
a great potential for genetic analysis of the regulation of this system.  We hope to identify 
genes that affect the trafficking, localization, and modulation of post-synaptic receptors 
that have conserved function in the mammalian nervous system.  Acetylcholine (ACh) plays 
highly conserved roles in neurotransmission.  ACh is the neurotransmitter involved in 
cholinergic signaling, which is essential to reward systems, nicotine addiction, and at the 
NMJ in mammals.  It is the primary excitatory neurotransmitter in C. elegans, and is 
released at the excitatory NMJ, as well in many connections in the nervous system.  Figure 1 
shows a model of the C. elegans NMJ.  Synaptic vesicles loaded with ACh fuse with the 
presynaptic cell membrane and release ACh into the synaptic cleft.  ACh binds to the ligand-
gated ACh channels (AChR), resulting in the opening of the channels.  This allows influx of 
Na+ and Ca2+ ions, depolarizing the post-synaptic cell.  The ACh in the synapse is inactivated 
when ACh esterase (AChE) removes the acetyl group from the choline, which is then 
recycled into the presynaptic cell.  
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AChRs are pentameric receptors that are homo- or heteromeric.  At least 27 
different AChR subunits are transcribed from the C. elegans genome (Rand, 2007).  This 
array of receptors allows for enormous variety in the receptor population.  Presumably, 
this diversity plays an important role in mediating fast synaptic transmission in both C. 
elegans and human nervous systems.  There are two classes of cholinergic receptors at the 
C. elegans NMJ: the heteromeric levamisole receptor (LevR), and the homomeric ACR-16.  
The LevR resembles heteromeric mammalian brain nAChRs, and ACR-16 resembles the 
mouse alpha 7 homomeric receptor (Rand, 2007). 
Many of the genes involved in cholinergic signaling at the NMJ have been previously 
characterized using pharmacological screens (Rand, 2007).  AChE inhibitors such as 
aldicarb prevent the inactivation and removal of ACh from the synapse.  In addition, 
levamisole acts as an agonist of the LevR.  When exposed to these drugs, the postsynaptic 
muscle cells in C. elegans are hyperactivated.  The muscles become hypercontracted, 
resulting in paralysis.  Knockout of genes required for cholinergic signaling confer 
resistance to these drugs.  Forward genetic screens for levamisole resistance have defined 
the subunits of the LevR, as well as genes involved in folding and trafficking of the receptor 
(Lewis et al, 1980).  Many of these mutations result in a complete loss of functional LevRs 
at the surface. The screens, however, have not found mutations in genes where the 
receptors would still be found at the surface of the cell, such as in genes that are specifically 
involved in the localization of the LevR.  As a result, an alternative strategy for identifying 
these genes will be an important tool for gaining a complete understanding of the 
mechanisms that regulate cholinergic signaling.  
A GAIN-OF-FUNCTION LEVR 
All AChR subunits have a conserved structure (Figure 2).  Each receptor subunit 
consists of four transmembrane domains.  The M2 transmembrane domain is a highly 
conserved region in these subunits and is thought to play an essential role in ion specificity 
and gating.  As in mammalian nAChRs, the LevR is composed of five different subunits.  The 
LevR is made up of three α subunits (LEV-8, UNC-38 and UNC-63) and two non-α subunits 
(LEV-1 and      UNC-29). 
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FIGURE 2.  HETEROMERIC ACETYLCHOLINE RECEPTORS AND THE LEVR(L/S) MUTATION.  [A] 
Structure of heteromeric AChRs.  Five distinct subunits combine to make the ionotropic 
receptor.  The M2 transmembrane domain lines the inside of the pore, and participates in 
the mediation of channel gating.  [B] The membrane topology of an AChR receptor 
subunit.  The site of the L/S mutation is indicated.  [C] Alignment of AChR subunits in the 
M2 transmembrane domain.  The site of an engineered serine mutation is indicated by the 
blue box in the subunits labeled with a red box.  UNC-29, UNC-38, LEV-1, LEV-8, and UNC-
63 are combined to make the LevR, a heteromeric acetylcholine receptor.  This region is 
highly conserved in ACR-16, the homomeric receptor found at the NMJ, and the mouse 
acetylcholine receptor subunits alpha 7 and beta 4.  Crystal structure taken from (Sixma, 
2007). 
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In the mouse model, generation of transgenic mice with a point mutation in 
acetylcholine receptors has helped to further understanding of the role these receptors 
play in the nervous system (Labarca, 2001).  A substitution with a polar amino acid near 
the gate in the M2 transmembrane region of the pore causes the receptor to stay open for 
much longer than in the wild type.  This M2 transmembrane region is conserved across the 
LevR subunits (UNC-29, UNC-38, LEV-1, LEV-8, and UNC-63), ACR-16, and mouse ALPHA7 
and BETA4 receptor subunits (Figure 2 C).  Previously, our lab introduced this mutation 
into the UNC-29, UNC-38, and LEV-1 subunits of the LevR to generate a gain-of-function 
LevR (LevR(L/S)).  UNC-29 and LEV-1 are specifically found in muscle (Rand, 2007), and all 
three of these subunits have shorter, more easily managed coding sequences.   
Coexpression of these mutated subunits on a single transgene caused a dramatic 
movement phenotype (Figure 3).  These animals are hypercontracted and have 
exaggerated body bends and a hooked head.  In addition, worms expressing the LevR(L/S) 
transgene were hypersensitive to levamisole and aldicarb.  In C. elegans, it is possible to 
dissect live animals and directly monitor cellular excitability using patch clamp 
electrophysiology in body wall muscles.  Animals are dissected so that their muscle cells 
are exposed, and electrodes are placed in the muscle cells of the animals to allow voltage-
clamp and current-clamp recordings.  We have previously used this technique to test if 
these phenotypes were the result of changes in receptor function.  We found that current 
responses from levamisole exposure were markedly slower in animals expressing 
LevR(L/S) .  These results suggest that the LevR(L/S) mutation causes a dramatic change in 
receptor function underlying the movement and hypersensitivity phenotypes we observed. 
THE EFFECT OF LEVR(L/S) ON MOTOR NEURONS AND MUSCLES 
Modulation of the signal from the presynaptic cell to the postsynaptic cell is an 
essential part of neural function, however, very little is known about the mechanisms that 
modify activity at the synapse.  The LevR(L/S) mutation may offer a way to probe how 
perturbations in neuronal activity can effect protein localization and connectivity in the 
motor circuit.   
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FIGURE 3.  LEVR(L/S)  INDUCES A CHANGE IN LEVR FUNCTION.  [A] Phenotype of LevR(L/S) 
worms.  Introduction of LevR(L/S) creates a dramatic movement phenotype, which is 
suppressed by several mutations acquired from a genetic screen.  [B] Worms expressing 
the LevR(L/S) are hypersensitive to the paralytic effects of aldicarb and levamisole.  Error 
bars depict standard error of the mean. [C] Patch-clamp recordings from wild type and 
LevR(L/S) worms with application of levamisole.  The black bar indicates a brief exposure 
of the muscle cell to levamisole.  In the gain-of-function, there is a very slow return to 
baseline, indicative of the channels staying open for longer and increased ion flow.  
In addition to agonistic, cholinergic neurons, C. elegans muscle cells are innervated 
by the motor neurons that release γ-aminobutyric acid (GABA), an inhibitor 
neurotransmitter at these synapses (Jorgensen, 2005).  When GABA is released, it opens 
chloride channels and hyperpolarizes the muscle.  The GABAergic motor neurons are also 
innervated by the cholinergic motor neurons (Figure 4).  One possible way in which the C. 
elegans locomotory circuit may be adapting to the presence of a gain-of-function ACh 
receptor is to increase GABAergic signaling in a compensatory fashion.   
 7 
 
 
FIGURE 4.  DIAGRAM OF THE MOTOR CIRCUIT.  Note that muscle cells are innervated by both 
excitatory cholinergic and inhibitory GABAergic motor neurons, and that the GABAergic 
motor neurons are innervated by the cholinergic neurons.  When the cholinergic motor 
neurons release ACh, the muscle they innervate contracts, but the GABAergic neuron it 
innervated causes the muscle on the other side to relax.  This in turn causes the  
characteristic sinusoidal motion of nematodes.  Figure taken from (Jorgensen, 2005). 
One way to assay GABAergic and cholinergic function is to examine the distribution 
of tagged release proteins expressed in the presynaptic cell.  RAB-3 is a G-protein that 
associates with the docking sites in neurons (Gracheva, Hadwiger, Nonet, & Richmond, 
2008).  In this project, we looked for changes in presynaptic release sites by examining the 
subcellular localization of a RAB-3 that is tagged with a red fluorescent reporter protein, 
mCherry.  In addition to effects on GABA and ACh release, we expected to see changes in 
levels and localization of the receptor populations on the muscle.  We explored these 
possibilities using florescent microscopy to examine the distribution of receptor subunits 
tagged with fluorescent reporter molecules. 
BEHAVIORAL IMPACTS OF LEVR(L/S) 
Cholinergic signaling mediates much more than merely muscular activity.  In C. 
elegans, cholinergic signaling is an important mediator of egg laying (Rand, 2007).  
However, knowledge of the full role of ACh in this process is complex.  ACh deficient 
animals are hyperactive egg-layers; however, levamisole has also been shown to induce egg 
laying.  Therefore, egg-laying behaviors may be strongly affected by the LevR(L/S) 
mutation, and may be a sensitive way of monitoring LevR activity.  We tested this 
hypothesis by recording quantitative differences in egg laying behaviors. 
 8 
 
A SUPPRESSOR SCREEN OF LEVR(L/S) 
The marked phenotype caused by the LevR(L/S) mutation in combination with the 
ease of genetics in C. elegans allows us to probe gene mutations that modify LevR signaling.  
Mutations in genes that suppress the phenotype of LevR(L/S) are likely to be involved in 
LevR signaling, and if these mutations do not confer levamisole resistance it is likely that 
they would not have been discovered using traditional pharmacological screens.   
Proteins can be easily removed in C. elegans via crossing deletion mutations into the 
LevR(L/S) background or knocking down with RNA interference (RNAi).  Previous studies 
have identified genes that are associated with the LevR using Tandem Affinity Purification 
of LevR complexes in combination with mass spectrometry to identify compounds 
associated with LevRs precipitated with antibodies (Gottschalk et al, 2005).  Because these 
proteins associate with the LevR, they may play an important role in its function.  Several of 
the genes (nra-2, nra-4) have been since implicated in homomeric receptor subunit 
composition at the C. elegans NMJ, but many of the isolated genes’ roles at the NMJ remain 
unclear (Banerjee et al 2005, Almedon et al 2009).  The LevR(L/S) mutation may provide a 
tool for further exploration into candidate genes involved in LevR signaling. 
We previously used suppression of the movement phenotype caused by LevR(L/S) 
to isolate suppressors from a forward genetic screen.  Alleles isolated from the screen have 
been given codes in the form ufXX.  As part of this project, we performed complementation 
tests to determine if the recessive mutations isolated were in the same gene.  Identified 
complementation groups are groups of mutations that fall in the same gene, and have been 
assigned the gene name Sal, for Suppressor of Activated LevR.  For more information on 
nomenclature, please see Appendix B.  One of the suppressors, sal-2(uf33), is a dominant 
suppressor of the gain-of-function movement phenotype.  Worms that have sal-2(uf33) 
have no other obvious movement phenotype.  Like LevR(L/S) alone, LevR(L/S);sal-2(uf33) 
animals are hypersensitive to levamisole and aldicarb (Figure 5).  Because the strain 
retains this sensitivity, we know that functional receptors are making their way to the 
surface.  Therefore, we hypothesize that the action the gene product identified by sal-
2(uf33) is in the localization or modulation of LevRs.  A major focus of this MQP was 
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mapping the general location of the gene affected by sal-2(uf33), as well as characterizing 
other suppressors from the screen. 
 
FIGURE 5.  LEVAMISOLE AND ALDICARB SENSITIVITY OF SAL-2(UF33).  sal-2(uf33) worms retain 
hypersensitivity to levamisole and aldicarb.   Note that unc-29(x29) animals, which lack 
the LevR, are completely resistant to levamisole.  Error bars depict standard error of the 
mean. 
SINGLE NUCLEOTIDE POLYMORPHISM MAPPING 
The potential for high throughput mapping of genes is one of the major advantages 
of C. elegans.  Advances in sequencing have allowed us to obtain the precise sequence of the 
entire genome of the wild type and many related C. elegans strains.  The N2 strain, which is 
the standard wild type strain, was isolated in Bristol, England (Davis et al, 2005).  Another 
closely related strain, CB4856, was isolated from Hawaii.  These strains have many single 
base pair differences between their genomes, called single nucleotide polymorphisms 
(SNPs)..  Many of these changes fall within recognition sequences for restriction enzymes, 
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with a cut site only found in one genotype.  This allows for the genotype at these SNPs to be 
easily determined: the area of DNA surrounding the SNP can be amplified using PCR and 
cut with the specific enzyme.  This provides us with an array of easily tracked genetic 
markers for mapping mutations.  Davis et al (2005) have developed a method for rapidly 
screening the genome using DraI SNPs evenly placed along chromosomes.   
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RESULTS 
In order to characterize the LevR(L/S) phenotype further, we created transgenic 
animals expressing GFP fused to proteins that function at the synapse to observe synapse 
morphology and localization defects.  We also performed an analysis of the egg laying 
behavior in the animals.  To determine whether specific genes were required for normal 
function of the LevR, we crossed deletions in candidate suppressors into the LevR(L/S) 
background and used RNAi to knock down the expression of candidate suppressing genes.  
To use an unbiased approach for identifying genes that modify LevR function, we 
conducted a forward genetic screen prior to this project for mutations that suppress the 
movement phenotype caused by the LevR(L/S) mutation.  We characterized these 
candidate suppressors using body bend analysis, levamisole resistance, and SNP mapping.  
LEVR(L/S) INDUCES A MOLECULAR HOMEOSTATIC RESPONSE 
In order to examine adaptive homeostatic changes at the NMJ in response to 
LevR(L/S) expression, we expressed fluorescently labeled markers in the LevR(L/S) 
background.  We chose both of the other known receptors at the C. elegans NMJ, ACR-16 
and the GABA receptor, as well as vesicle markers in the different classes of motor neuron 
to look for changes in presynaptic morphology.  We also mis-expressed a subtype of 
ionotropic glutamate receptor (GluR) in body wall muscle, which normally does not 
express GluRs, as a negative control.  In C. elegans, the muscles extend cellular projections 
to the central nerve cord called muscle arms.  At the nerve cord, these muscle arms form 
synaptic contacts with motor neuron processes.   Receptors and vesicle markers cluster at 
synapses, and thus puncta observed in animals expressing these markers represent 
synapses.    
We observed no significant change in the localization of any of these markers, 
excepting ACR-16.  In LevR(L/S) animals, we observed that ACR-16 was dramatically 
absent from the nerve cord, and was instead found retained in the muscle cell bodies 
(Figure 6).  A suppressor we isolated in the forward genetic screen, sal-2(uf33), rescued 
this mislocalization.  We also expressed a membrane-bound yellow fluorescent protein in 
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muscle cells that allowed us to observe gross muscle arm structure.  Muscle arms in 
LevR(L/S) animals appeared to be thinner.  These results suggest the cells may be 
compensating for the LevR(L/S) by mislocalizing or retaining the ACR-16 receptor and by a 
change in muscle arm morphology.  
 
FIGURE 6.  LEVR(L/S)  INDUCED A RESCUABLE MISLOCALIZATION OF ACR-16 WITHOUT 
AFFECTING OTHER MARKERS.  [A] Cartoon of the ventral view of C. elegans.  Images were 
taken in the boxed area.  [B] When LevR(L/S) was co-expressed with a GFP fused ACR-16, 
the ACR-16 was largely absent from the nerve cord.  It was instead aggregated in the 
muscle cell bodies, indicated by white triangles.  (Top two panels).  This mislocalization 
was rescuable by sal-2(uf33) (Third panel).  Co-expression with other markers revealed 
no significant difference in the localization of presynaptic components or other receptors 
expressed in muscle cells.  [C] Quantification of number of puncta in a fixed area of the 
ventral nerve cord.  For ACR-16, statistical significance was calculated using ANOVA and 
Tukey HSD.  *=p<0.001. All other samples were compared using the Independent Samples 
T-test, and were found to not be significantly different. Error bars depict standard error 
of the mean. 
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LEVR(L/S) INDUCES CONSTITUATIVE EGG LAYING 
Cholinergic signaling plays an important role in the egg-laying behaviors of C. 
elegans (Rand, 2007), so we hypothesized that a hyper-activated LevR would induce 
constitutive egg laying.  To test this we monitored the number of eggs retained in the 
uterus after 24 hours, as well as the number of eggs laid every 12 hours following L4 stage 
(Figure 7).  Twenty-four hours after L4 stage, worms that express LevR(L/S) had very few 
eggs in their uteri as compared to wild type.  The eggs laid by these animals were much 
earlier staged, usually between the 4 and 12 egg stage as opposed to the >40 cell stage of 
eggs laid by wild type animals.  Although eggs were laid earlier by worms expressing 
LevR(L/S) than by wild type animals, the animals had no overall change in brood size.  
Taken together, these results suggest that LevR(L/S) induces constitutive egg laying.  In 
addition, the suppressor of the LevR(L/S) movement phenotype sal-2(uf33) only partially 
suppresses this phenotype, and thus quantification of egg laying may represent a more 
subtle way of looking at cholinergic signaling than the movement phenotype or indicating a 
distinct, cell-specific, role of sal-2(uf33) in the egg laying circuitry. 
RESULTS OF A CANDIDATE SUPRESSOR SCREEN  
As previously mentioned, suppressors of the LevR(L/S) movement phenotype may 
be involved in the regulation or localization of the receptor.  To look for genes of interest 
and to demonstrate the efficacy of a forward suppressor screen for novel mutations, we 
used a candidate gene approach to find gene knockouts that suppress the movement 
phenotype.  We chose to examine the effect of knocking down genes representing distinct 
functional classes: acr-16, the homomeric nAChR found at the C. elegans NMJ, itsn-1, which 
has been implicated in cholinergic function (Wang et al, 2008), and tam-1, a gene require 
for expression of repetitive DNA sequences as in the multi-copy transgene carrying the 
LevR(L/S) mutation (Hsieh et al, 1999).  We also chose genes that are known levamisole 
resistance genes or are identified as interacting with LevRs (Gottschalk et al, 2005).  Using 
RNAi or by crossing in deletions in the genes, we determined whether each of these genes 
were required for the LevR(L/S) movement phenotype.  Results are shown in Table 1. 
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FIGURE 7.  LEVR(L/S)  INDUCED CONSTITUTIVE EGG LAYING.  [A] Eggs laid by LevR(L/S) 
animals were at an earlier stage than those laid by wild-type animals.  Later stage eggs 
had more cells, and there were fewer eggs retained in the vulva.  Image taken by DIC.  [B] 
Quantification of number of eggs retained in the uterus after 24 hours.  LevR(L/S) animals 
had a marked decrease in the number of eggs retained.   Animals with the sal-2(uf33) 
mutation partially suppressed this phenotype.  Statistical significance was calculated 
using ANOVA and Tukey HSD.  [C] Time course of eggs laid by staged animals.  LevR(L/S) 
animals laid more eggs earlier than wild-type animals as indicated by the change in 
inflection point of the curve.  Error bars depict standard error of the mean. 
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TABLE 1.  CANDIDATE SUPPRESSOR SCREEN OF THE LEVR(L/S) MOVEMENT PHENOTYPE.  Genes 
were chosen because they were known levamisole resistance genes, they are associated 
with the LevR (Gottschalk et al, 2005), and from other evidence that they may be involved 
in LevR localization. 
  Gene Description 
Knockdown 
Type 
Suppression 
Le
va
m
is
o
le
 
R
es
is
ta
n
ce
 G
e
n
e
s 
lev-10 CUB domain protein, involved in LevR localization Deletion - 
ric-3 LevR chaperone RNAi + 
unc-50 LevR trafficking RNAi + 
unc-63 LevR subunit Deletion + 
unc-74 Required for Surface Expression Deletion + 
A
ss
o
ci
at
e
d
 w
it
h
 L
ev
R
 kin-20 
Casein kinase I, Drosophila double-time homolog 
(Banerjee et al, 2005) 
RNAi + 
nra-1 Copine 
RNAi, 
Deletion 
- 
nra-2 
Nicalin homologue, ER transmembrane involved in 
receptor composition (Almedom et al, 2009) 
RNAi - 
nra-3 PHD (Zn-)finger RNAi - 
pgp-12 P-glycoprotein RNAi - 
soc-1 Pleckstrin homology domain RNAi - 
tax-6 Calcinerurin A subunit RNAi - 
O
th
er
 acr-16 nAChR subunit Deletion - 
itsn-1 Intersectin Deletion - 
tam-1 Regulates transgene expression Deletion + 
 
Deletions of ric-3, unc-50, unc-63, and unc-74 all eliminate surface expression of the 
LevR and suppressed the LevR(L/S) movement phenotype as expected.  lev-10 is a CUB-
domain protein thought to be required for LevR localization (Gally et al 2004).  
Interestingly, deletion of lev-10 did not suppress LevR(L/S).  We hypothesized that lev-10 is 
not sufficiently involved in the localization of the LevR for the deletion to affect LevR 
signaling.  To test this, we created a strain carrying deletion alleles of both acr-16 and lev-
10.  With no ACR-16 receptors at the neuromuscular junction, if lev-10 had a strong effect 
on the localization of LevR(L/S) we would expect this strain to be paralyzed or severely 
uncoordinated,  However, these animals displayed no visible phenotype (data not shown). 
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Of the genes isolated by Gottschalk et al, only kin-20 substantially suppressed the 
LevR(L/S) phenotype.  kin-20 is a Drosophila double-time homolog, and has been implicated 
as a major player in developmental timing.  acr-16 did not suppress the LevR(L/S) 
phenotype.  itsn-1 plays a role in cholinergic vesicle release, and did not suppress the 
LevR(L/S) phenotype. This suggests that suppressors of the phenotype are likely to act 
post-synaptically.  Deletion of tam-1 suppressed the LevR(L/S) phenotype, presumably by 
knocking down expression of the LevR(L/S) transgene.  We would therefore expect to pull 
alleles of tam-1 out of a forward genetic screen for suppressors.  Taken together, these 
results support the view that a forward genetic screen for suppressors may be a useful tool 
for identifying novel genes involved in cholinergic signaling. 
ANALYSIS OF SUPPRESSORS OF LEVR(L/S) FOUND IN A FORWARD GENETIC SCREEN 
To find novel genes involved in LevR signaling, we conducted a forward 
mutagenesis screen for suppressors of the LevR(L/S) movement phenotype (Table 2).  We 
performed complementation tests on the alleles, and determined that they represent at 
least seven different genes, including tam-1 (Table 3). 
We hypothesized that mutations that suppress the LevR(L/S) phenotype and confer 
levamisole resistance are likely to represent mutations in genes already characterized from 
levamisole resistance screens.  Of interest to us are novel genes that have more subtle 
effects on LevR signaling and are therefore not likely to have been previously described.  
We therefore predicted that mutant stains of interest would be sensitive to the paralytic 
effects of levamisole.  To focus our characterization on these likely novel candidates, we 
examined the movement speed and sensitivity to the paralytic effects of levamisole (Figure 
8).  Many of the strongest suppressors of the LevR movement phenotype remained highly 
sensitive to levamisole, and thus are target mutations of interest.  
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TABLE 2.  SUMMARY OF ALLELES ISOLATED FROM SUPPRESSOR SCREEN.  Alleles that have been 
found to fail-to-complement the known gene tam-1 are marked.  Complementation groups 
for which the gene is not yet known have been temporarily assigned the gene name sal, for 
suppressor of activated LevR.  Alleles with no entry in the gene column are not yet mapped 
or are not yet known to fall in a complementation group. 
Allele Gene Dominance Notes 
uf14 sal-1 Recessive Runs into body on direction changes 
uf33 sal-2 Dominant Wild type 
uf40 sal-3 Recessive Very deep body bends, few reversals 
uf42 sal-3 Recessive Long, uncoordinated reversals 
uf44 sal-4 Dominant Few reversals 
uf50 sal-5 Recessive 
Stuttering movement, faster but visibly 
uncoordinated 
uf55 sal-6 Recessive 
Very short reversals, backwards movement 
much less fluid 
uf13 tam-1 Recessive Wild type 
uf31 tam-1 Recessive Wild type 
uf32 tam-1 Recessive Wild type 
uf45 tam-1 Recessive Wild type 
uf49 tam-1 Recessive Wild type 
uf47 
 
Dominant Wild type 
uf48 
 
Dominant Some short, jerky reversals 
uf52 
 
Dominant Head lifts off agar 
uf53 
 
Recessive 
Jerky movement and shallow body bends.  
Head lifts off agar. 
uf54 
 
Recessive Uncoordinated 
uf56 
 
Recessive 
Short reversals stuttered, long reversals 
very long 
uf57 
 
Recessive Very uncoordinated 
uf58 
 
Recessive 
Long, uncoordinated reversals.  Worms 
uncoordinated and small. 
uf59 
 
Dominant 
Hyper foraging, short distances before stop, 
stuttering movement 
  
 
1
8
 
 
 
 
 
TABLE 3.  COMPLEMENTATION SUMMARY OF SUPPRESSORS.  Complementation tests that have resulted in complementation 
(different genes) are highlighted in blue, failed to complement (same gene) are highlighted in red.  White tests remain to be 
completed, and grey indicates a redundant test.  
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FIGURE 8.  BODY BEND AND LEVAMISOLE RESISTANCE ANALYSIS OF SUPPRESSORS.  Suppressors 
that are most likely to be not previously characterized are those that restore wild type 
movement, while still being hypersensitive to levamisole.  We measured movement speed 
by counting the number of body-bends made by an animal per minute, and examined 
levamisole sensitivity by observing the percentage of animals paralyzed after one hour on 
plates containing 200 μM levamisole.  LevR deletion animals contain the unc-63(ok789) 
knockout allele, have no functional LevRs, and thus are completely resistant to levamisole.  
The grey dotted line shows the average levamisole sensitivity of N2 animals, and the black 
dotted line shows the average movement speed of LevR(L/S) animals.   For example, sal-
2(uf33) fully rescues the movement phenotype of LevR(L/S), while retaining levamisole 
sensitivity.  Error bars depict standard error of the mean.  
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MAPPING SUPPRESSORS OF LEVR(L/S) 
To identify the genes mutated by the suppressors of LevR(L/S) we isolated, we used 
a SNP mapping.  We obtained several dominant suppressors of the LevR(L/S) movement 
phenotype from our screen that may represent gain-of-function alleles, dominant negative 
alleles, or genes that are haploinsufficient for enabling the LevR(L/S) phenotype.  For 
dominant suppressors, it is sufficient to backcross the suppressor into the Hawaiian 
background when the LevR(L/S) mutation is kept present.  We have performed extensive 
mapping analysis of sal-2(uf33).  sal-2(uf33) is of particular interest because it restores 
wild-type movement, while conferring no resistance to levamisole.  The most likely 
position of sal-2(uf33) is on the left side of chromosome II, as that is where N2 markers are 
most conserved (Figure 9). 
FIGURE 9.  SNP MARKERS IN SAL-2(UF33) BACKCROSSED STRAINS.  The area boxed in grey is 
the area close to the LevR(L/S) transgene.  Because the markers are most constantly N2 
type on the left side of two, it is likely that sal-2 is somewhere on the left of two.  Markers 
marked null have not enough data to determine whether any markers are Hawaiian.  
Isolates 5-n are a 3x backcross to LevR(L/S);CB4856, isolates 1-n are a 9 X backcross.  
PCR was only performed on the 9x backcrosses on chromosomes I and II.  
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DISCUSSION 
Patients with slow-channel congenital myasthenic syndrome (SCCMS) have a 
mutation in AChRs in their skeletal muscles similar to the one found in LevR(L/S), causing 
a dramatic change in channel kinetics.  Over time, hyperactivation of the nAChRs induces 
homeostatic pathways that lead to endplate myopathy, muscle weakness, and loss of 
muscle control (Engel et al, 2010).  A homologous mutation in brain nAChRs has been 
shown to cause autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and benign 
familial neonatal convulsions (Barrantes et al, 2000).  The distinct mislocalization 
phenotype of ACR-16 and apparent effect on the morphology of muscle arms in LevR(L/S) 
animals may be the result of activation of homologous pathways in the worm.  Our 
LevR(L/S) may provide a model system for these diseases, and the suppressors of 
LevR(L/S) may identify targets for therapies for SCCMS and ADNFLE patients.  In addition 
to the use of this as a model system, this phenotype may indicate that there is an important 
balancing act between cholinergic signaling by the LevR and the ACR-16 receptor.  The 
homeostatic mechanisms that maintain this balance may play important roles in 
maintenance of excitability and in plasticity.   
An obvious potential homeostatic response to increased LevR activity would be a 
change in localization of the LevR itself.  However, attempts to visualize the LevR by 
addition of a GFP tagged LevR subunit, UNC-29, reduced the LevR(L/S) movement 
phenotype.  We hypothesize that this result occurred because the GFP tagged UNC-29 was 
competing with the gain-of-function UNC-29 in the LevR(L/S) transgenic array (work done 
prior to MQP).  Possible ways to view localization of the receptor would be to tag a subunit 
not in the LevR(L/S) mutation and express it only n muscle or to create antibodies against 
the LevR.   We generated a cloning strategy to tag the LevR subunit UNC-63 with GFP that 
can be seen in Appendix A. 
The constitutive egg laying phenotype caused by the LevR(L/S) mutation represents 
a dramatic effect of increased cholinergic signaling.  In addition, sal-2(uf33) only partially 
rescues the egg laying phenotype, while fully rescuing the movement phenotype.  This 
result suggests that cholinergic signaling via the LevR may still be increased in 
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LevR(L/S);sal-2(uf33) and that the movement rescue by sal-2(uf33) is caused by some 
subtle effect on LevR signaling, or that sal-2(uf33) acts differently in the vuvlal musculature 
than it does in body-wall muscle.  This also supports the differential role of ACh in muscles 
as promoting egg laying, while inhibiting egg laying in the nervous system.  Egg laying is 
known to be suppressed only when cholinergic signaling is present, but the drug 
levamisole also causes the release of eggs (Rand, 2007).  The partial rescue by sal-2(uf33) 
demonstrated that this technique may serve as a useful assay for uncovering more subtle 
effects on LevR signaling. 
Of the candidate suppressors chosen, only strong levamisole resistance genes, kin-
20, and tam-1 knockouts suppressed the LevR(L/S) phenotype.  The strong levamisole 
resistance genes were expected to suppress LevR(L/S) as the receptor is eliminated from 
the cell surface, and tam-1 knockout is known to silence repeated sequences such as the 
multi-copy array containing our mutated subunit.  kin-20 was the only other candidate that 
suppressed the LevR(L/S) phenotype by RNAi; however, kin-20 in heavily involved in 
development and animals with the knockout of kin-20 are very sick and uncoordinated.  
That none of the knockouts of known genes that associate with the LevR that do not affect 
levamisole sensitivity suppressed the LevR(L/S) and that many of the suppressors isolated 
from the forward genetic screen do suggest that these mutations may be in genes that have 
not yet been implicated in cholinergic signaling.  We may expect that a forward genetic 
screen will reveal novel genes involved in modulation and localization of LevR. 
We believe that the LevR(L/S) mutation provides a useful approach to exploring 
cholinergic function.  We have shown that the LevR(L/S) mutation induces a dramatic 
movement and egg laying phenotype, as well as a potential homeostatic response.  We have 
obtained many suppressors from a forward genetic screen that would have been difficult to 
identify using pharmacological screen.  We have begun to identify these genes using SNP 
mapping, and are confident that identification of these genes will lead to new insights in 
how receptors are managed in synaptic communication. 
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METHODOLOGY 
COMPLEMENTATION TESTS 
To determine whether mutations isolated from the forward genetic screen fell on 
the same gene, we performed complementation tests (Figure 10).  Males of one recessive 
suppressor were crossed with hermaphrodites of a different recessive suppressor strain.  If 
all of the cross progeny moved normally, they each received a mutant allele of the gene that 
suppressed LevR(L/S), and thus both mutations were in the same gene.  Males are denoted 
by a ♂, hermaphrodites by . 
♂𝐿𝑒𝑣𝑅 𝐿/𝑆 ; 𝑠𝑢𝑝𝑟𝑒𝑠𝑠𝑜𝑟𝐴 × 𝐿𝑒𝑣𝑅 𝐿/𝑆 ; 𝑠𝑢𝑝𝑟𝑒𝑠𝑠𝑜𝑟𝐵  
 
 
𝐿𝑒𝑣𝑅 𝐿/𝑆 ;
𝑠𝑢𝑝𝑟𝑒𝑠𝑠𝑜𝑟𝐴
𝑠𝑢𝑝𝑟𝑒𝑠𝑠𝑜𝑟  𝐵
                                          𝐿𝑒𝑣𝑅 𝐿/𝑆 ;
𝑠𝑢𝑝𝑟𝑒𝑠𝑠𝑜𝑟𝐴
+
;
𝑠𝑢𝑝𝑟𝑒𝑠𝑠𝑜𝑟  𝐵
+
 
𝑤𝑖𝑙𝑑 𝑡𝑦𝑝𝑒 𝑚𝑜𝑣𝑒𝑚𝑒𝑛𝑡                                                𝑢𝑛𝑐𝑜𝑜𝑟𝑖𝑛𝑎𝑡𝑒𝑑               . 
FIGURE 10.  DIAGRAM OF COMPLEMENTATION TEST.  If suppressor A  and suppressor B are in 
the same gene, then all cross progeny will carry two mutant alleles of the gene and will 
continue to suppress LevR(L/S).  However, if the genes are different, then they will be 
heterozygous for both recessive mutations, and the worms will be uncoordinated as 
LevR(L/S) animals are. 
CROSS STRATEGIES 
In order to explore aspects of cholinergic signaling, we took advantage of the genetic 
flexibility in C. elegans to perform crosses.  Males were generated by heat shocking L4 stage 
animals for two six-hour periods separated by a 15-minute room temperature recovery 
period.  Worms carrying lin-15(n765ts), a temperature sensitive marker we used for 
transgenics, were similarly generated, except they were allowed to recover at 15 degrees 
and were returned to 15 degrees immediately following heat shock.  Some of the stains 
included here were generated, but have not yet be used to generate data.  There were four 
general strategies used to create strains, shown in the figures below. 
Same gene Different genes 
 24 
 
ufIs23 is a transgenic array where a GFP fused channelrhodopsin-2 (ChR2) is 
expressed under a cholinergic-motor neuron specific promoter, pacr-2.  ChR2 is a light-
gated ion channel involved in photosensitivity in algae (Nagel et al, 2003).  We can express 
ChR2 cell specifically using the transgenic power of C. elegans.  ChR2 changes conformation 
under exposure to blue light, allowing allow ion flow and depolarizing the neurons 
expressing it.  We can use this as a switch to turn on specific neurons, allowing us to use 
electrophysiology to directly see synaptic responses.   
♂𝐿𝑒𝑣𝑅 𝐿/𝑆 ; 𝑢𝑓33 × 𝐿𝑒𝑣𝑅 𝐿/𝑆 ; 𝑢𝑓𝐼𝑠23(𝑝𝑎𝑐𝑟 − 2 ∷ 𝐶𝑕𝑅2 ∷ 𝐺𝐹𝑃)  
↓ 𝑃𝑖𝑐𝑘 𝑛𝑜𝑛 𝑢𝑛𝑐 𝑕𝑒𝑟𝑚𝑎𝑝𝑕𝑟𝑜𝑑𝑖𝑡𝑒𝑠 
𝐿𝑒𝑣𝑅 𝐿/𝑆 ;𝑢𝑓33/+; 𝑢𝑓𝐼𝑠23/+ 
↓ 𝑃𝑖𝑐𝑘 26 𝑛𝑜𝑛 𝑢𝑛𝑐, 𝐺𝐹𝑃 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑕𝑒𝑟𝑚𝑎𝑝𝑕𝑟𝑜𝑑𝑖𝑡𝑒𝑠 
𝐹𝑟𝑜𝑚 𝑡𝑕𝑒 𝑛𝑒𝑥𝑡 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛 𝑠𝑐𝑟𝑒𝑒𝑛 𝑝𝑙𝑎𝑡𝑒𝑠 𝑓𝑜𝑟  
𝑕𝑜𝑚𝑜𝑧𝑦𝑔𝑜𝑢𝑠 𝑛𝑜𝑛 𝑢𝑛𝑐, 𝐺𝐹𝑃 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 
𝐿𝑒𝑣𝑅 𝐿/𝑆 ; 𝑢𝑓33; 𝑢𝑓𝐼𝑠23 
FIGURE 11.  CROSS STRATEGY FOR GENERATION OF LEVR(L/S);SAL-2(UF33);UFIS23(PACR-
2::CHR2::GFP).  ufIs23(pacr-2::ChR2::GFP) is the acr-2 promoter driving 
expression of a GFP fused channelrhodopsin, allowing us to use light to activate the 
motor neurons that innervate muscles. 
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♂𝐿𝑒𝑣𝑅 𝐿/𝑆 ; 𝑢𝑓33 × 𝐿𝑒𝑣𝑅 𝐿/𝑆 ; 𝑎𝑐𝑟 − 16(𝑜𝑘789)  
↓ 𝑃𝑖𝑐𝑘 𝑛𝑜𝑛 𝑢𝑛𝑐 𝑕𝑒𝑟𝑚𝑎𝑝𝑕𝑟𝑜𝑑𝑖𝑡𝑒𝑠 
𝐿𝑒𝑣𝑅 𝐿/𝑆 ;𝑎𝑐𝑟 − 16(𝑜𝑘789)/+;𝑢𝑓33/+ 
↓ 𝑃𝑖𝑐𝑘 12 𝑛𝑜𝑛 𝑢𝑛𝑐 𝑕𝑒𝑟𝑚𝑎𝑝𝑕𝑟𝑜𝑑𝑖𝑡𝑒𝑠 𝑎𝑛𝑑 𝑐𝑜𝑛𝑓𝑖𝑟𝑚 𝑏𝑦 𝑃𝐶𝑅 
𝐿𝑒𝑣𝑅 𝐿/𝑆 ;𝑎𝑐𝑟 − 16(𝑜𝑘789);𝑢𝑓33/+ 
↓ 𝑃𝑖𝑐𝑘 12 𝑛𝑜𝑛 𝑢𝑛𝑐 𝑕𝑒𝑟𝑚𝑎𝑝𝑕𝑟𝑜𝑑𝑖𝑡𝑒𝑠. 
𝐹𝑟𝑜𝑚 𝑡𝑕𝑒 𝑛𝑒𝑥𝑡 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛 𝑠𝑐𝑟𝑒𝑒𝑛 𝑝𝑙𝑎𝑡𝑒𝑠 𝑓𝑜𝑟  
𝑕𝑜𝑚𝑜𝑧𝑦𝑔𝑜𝑢𝑠 𝑛𝑜𝑛 𝑢𝑛𝑐. 
𝐿𝑒𝑣𝑅 𝐿/𝑆 ;𝑎𝑐𝑟 − 16(𝑜𝑘789); 𝑢𝑓33 
FIGURE 12.  CROSS STRATEGY FOR GENERATION OF LEVR(L/S);SAL-2(UF33);ACR-16(OK789).   
In the absence of acr-16, we can use ChR2 to specifically drive the response of the 
LevR at synapses. 
 
♂𝐼𝑠? (𝐹𝑙𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑡 𝑡𝑎𝑔𝑔𝑒𝑑 𝑎𝑟𝑟𝑎𝑦)  × 𝐿𝑒𝑣𝑅 𝐿/𝑆  
↓ 𝑃𝑖𝑐𝑘 𝐺𝐹𝑃 𝑜𝑟 𝑚𝐶𝑕𝑒𝑟𝑟𝑦 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑕𝑒𝑟𝑚𝑎𝑝𝑕𝑟𝑜𝑑𝑖𝑡𝑒𝑠 
𝐼𝑠?/+; 𝐿𝑒𝑣𝑅 𝐿/𝑆 /+ 
↓ 𝑃𝑖𝑐𝑘 26 𝑢𝑛𝑐, 𝐺𝐹𝑃 𝑜𝑟 𝑚𝐶𝑕𝑒𝑟𝑟𝑦 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 
𝑕𝑒𝑟𝑚𝑎𝑝𝑕𝑟𝑜𝑑𝑖𝑡𝑒𝑠. 𝑆𝑐𝑟𝑒𝑒𝑛 𝑛𝑒𝑥𝑡 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛 𝑓𝑜𝑟  
𝑝𝑙𝑎𝑡𝑒𝑠 𝑡𝑕𝑎𝑡 𝑎𝑟𝑒 𝑕𝑜𝑚𝑜𝑧𝑦𝑔𝑜𝑢𝑠 𝑢𝑛𝑐, 𝐺𝐹𝑃 𝑜𝑟 
𝑚𝐶𝑕𝑒𝑟𝑟𝑦 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒. 
𝐼𝑠? ; 𝐿𝑒𝑣𝑅 𝐿/𝑆  
FIGURE 13.  CROSS STRATEGY FOR MARKING LEVR(L/S) WITH A FLUORESCENT TAG. 
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♂𝑁2 × 𝑚𝑢𝑡  
↓ 
♂𝑚𝑢𝑡/+ × 𝐿𝑒𝑣𝑅(𝐿/𝑆)  
↓ 
𝑚𝑢𝑡/+; 𝐿𝑒𝑣𝑅(𝐿/𝑆)/+ 
↓ 𝐶𝑜𝑛𝑓𝑖𝑟𝑚 𝑣𝑖𝑠𝑢𝑎𝑙𝑙𝑦 𝑜𝑟 𝑏𝑦 𝑃𝐶𝑅 
𝑚𝑢𝑡; 𝐿𝑒𝑣𝑅(𝐿/𝑆)/+ 
↓ 𝐶𝑜𝑛𝑓𝑖𝑟𝑚 𝑣𝑖𝑠𝑢𝑎𝑙𝑙𝑦 𝑜𝑟 𝑏𝑦 𝑃𝐶𝑅 
𝑚𝑢𝑡; 𝐿𝑒𝑣𝑅(𝐿/𝑆) 
FIGURE 14.  CROSS STRATEGY FOR MAKING DOUBLE MUTANTS WITH LEVR(L/S). 
 
SINGLE NUCLEOTIDE POLYMORPHISM (SNP) MAPPING 
To determine where the suppressors isolated from of the forward genetic screen 
were located in the C. elegans genome, we used a modification of the protocol developed by 
Davis et al for mapping using single nucleotide polymorphisms, or SNPs, between the 
Bristol strain (N2) and the Hawaiian strain (CB4856).  These polymorphisms can introduce 
or eliminate a restriction enzyme recognition site, and in combination with PCR can be 
used to determine the location of genes quickly.   
Prior to this MQP, we developed a variant of the technique developed by Davis et al 
to begin to map dominant mutations (Figure 15).  The mutations acquired from the genetic 
screen were selected for their lack of phenotype other than suppressing LevR(L/S).  As a 
result, the suppressors had to be mapped in the presence of the LevR(L/S) transgene.  To 
overcome this obstacle, we backcrossed two integrants of the LevR(L/S) transgene to the 
Hawaiian strain: one integrated on LGII and one integrated LGV.  We compared the 
backcrossed lines to N2, and showed that the LGII variant displayed Hawaiian markers on 
all other chromosomes.  The LGII variant shows Hawaiian SNP markers at -18, -14, and +22 
CM, whereas the LGV variant shows Hawaiian SNP markers all across LGII (Figure 16).  SNP 
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mapping could then be performed by selecting for suppression of the LevR(L/S).  Dominant 
mutations can be serially backcrossed to these strains, allowing fine breakpoints to be 
determined by crossing away N2 markers. 
 
FIGURE 15.  SNP MAPPING STRATEGY FOR DOMINANT SUPPRESSORS.  The N2 (blue) and 
Hawaiian (red) regions of the chromosomes are distinguished by SNPs, which can be 
identified by PCR and restriction digests.  A mutation shown by the black bar is crossed 
into the Hawaiian background.  When cross progeny have wild type movement, they are 
heterozygous for the dominant suppressor.  Males are continuously crossed back into the 
Hawaiian background.  When crossing over occurs, N2 markers are lost at positions far 
from the mutation.  When the mutation is re-isolated, the region very close to the 
mutation will always show N2 SNPs.  Further away from the  mutation, however, 
recombination will occur and Hawaiian SNPs will be observable.  
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FIGURE 16.  GENOTYPES ON LGII OF LEVR(L/S)  STRAINS USED FOR MAPPING.  Genetic locations 
in cM are surrounded by brackets.  Each bracket shows the N2 marker, followed by the 
marker carried by the LevR(L/S) backcrossed line, followed by the Hawaiian marker.  
Asterisks show markers that present the Hawaiian SNP.  [A] The integrant for which the 
screen was performed ; the LevR(L/S) transgene is integrated on LGII.  The Hawaiian 
backcross presents Hawaiian markers at all locations other than LGII (not shown).   [B]  
Another LevR(L/S) integrant, integrated on LGV, was also backcrossed and presents 
Hawaiian markers all across LGII, allowing us to locate suppressors anywhere in the 
genome.  
CLONING OF PMYO-3::UNC-63::GFP 
An important part of characterizing the function of the LevR is viewing expression 
patterns.  However, when a GFP tagged UNC-29 subunit was co-expressed with the gain-of-
function LevR(L/S) transgene, there was a marked reduction in the LevR(L/S) movement 
phenotype, presumably due to competition between the gain-of-function and GFP tagged 
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subunits.  In order to overcome this obstacle, we wanted to express GFP in a subunit not 
expressed in the LevR(L/S) transgene, namely, UNC-63.  Previous work has shown that GFP 
tagged receptor subunits are primarily functional when inserted into the cytosolic loop of 
the subunit.  The strategy developed can be found in Appendix A.  Our initial attempts to 
make the clone were unsuccessful. 
BODY BEND ANALYSIS 
In order to measure the suppression of the LevR(L/S) phenotype quantitatively, we 
used analysis of the rate of body bends in the animals.  We staged worms at L4 stage.  
Twenty-four hours later, the worms were videotaped on plates without food.  The number 
of body bends over the course of five minutes was counted. 
LEVAMISOLE SENSITIVITY 
To measure the function of the LevR, we used assays to measure levamisole 
sensitivity.  Worms were assayed twenty-four hours after L4 stage.  Worms were placed on 
NGM plates containing levamisole.  For time course assays, 100 μM levamisole was used 
and paralyzed worms were removed and counted every fifteen minutes.  For rough 
levamisole assays, worms were placed on 200 μM levamisole for one hour.   
EGG LAYING ASSAYS 
Egg laying is one function that is dependent on cholinergic processes (Rand, 2007).  
Treatment with levamisole can induce constitutive egg laying.  To determine the egg laying 
phenotypes of LevR(L/S), worms were dissolved in bleach twenty-four hours following L4, 
and the eggs in the vulva were counted.  In addition, worms were staged at L4 and every 12 
hours picked to new plates.  The numbers of eggs laid by each worm during each 12-hour 
interval were then counted. 
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THE FORWARD GENETIC SCREEN 
Although not conducted as part of this project, the resulting strains from the genetic 
screen for suppressors of LevR(L/S) play an important role in this project.  As a pilot 
screen, LevR(L/S) worms were mutagenized using ethyl-methanesulfate according to the 
protocol by Koelle (1994).  F2s from the mutagenesis were visually scanned for improved 
movement.  Following this screen an additional, more directed screen was performed.  
Plates were marked with 1 mm markers, and were referred to as race plates.  F2s from 
mutagenesis were pelleted in M9 solution when the worms were primarily young adults.  
Pelleted worms were dropped along the starting line in 2 μL drops, each drop containing 
~50 worms (Figure 17).  The worms would then tax towards the drop of food on the finish 
line.  In general, wild type animals would arrive at the food after 30 minutes, and LevR(L/S) 
animals would arrive after 2 hours.  Every 15 minutes, the mutagenized worms that made 
it to the food were picked clonally to new plates, and in the next generation, the worms 
were screened for improved movement.  
 
FIGURE 17.  RACE PLATE DIAGRAM.  Pelleted adult animals were dropped along the left, and 
a drop of food was placed on the right.   
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APPENDIX B. C. ELEGANS NOMENCLATURE AND TRANSGENICS 
C. elegans is a useful genetic organism, so it is important to discuss the 
nomenclature of the field of C. elegans research and to clarify how transgenic lines are 
created.  
C. elegans strains are each given a strain name.  The most common of these strains is 
the N2 strain, isolated in Bristol, England.  This is a wild type strain, and variants of this 
strain are used in many fields of research.  Each gene in the C. elegans genome is given a 
three-letter code, followed by a number.  The three-letter code refers to the type of the 
gene, and the number is specific to that gene.  For example, acr-16 is an Acetyl Choline 
Receptor subunit, coded 16.  When referring to the gene, it is shown in lower case italics, 
and when referring to the protein product of the gene it is shown in all upper case.  Alleles 
of a gene are shown following the gene name in parentheses.  For example, acr-16(ok789) 
is a deletion allele of acr-16.  When a strain caries more than one mutation, it is separated 
by a semicolon (e. g. acr-16(ok789);unc-29(x29) ). 
C. elegans are also extremely useful in the creation of transgenics.  When plasmid 
DNA is injected into the gonad of a young adult animal, the developing ova create a 
chromosome-like structure from the inserted DNA called an extrachromosomal array.  This 
array is randomly lost in some cells of each animal, as well as in some progeny of the 
animal.  In order to create a stability transmitting transgenic line, X-rays are used to 
introduce double stranded breaks in the chromosomal DNA.  In a small percentage of 
animals, DNA repair mechanisms will randomly incorporate the extrachromosomal array 
into the chromosomal DNA, and the array becomes integrated.   These animals are selected 
based on the stable transmission to all progeny. 
